Effect of Vancomycin Applied to the Surgical Site on Fracture Healing in a Diabetic Rat Model
Foot & Ankle International · 2023
DOI: 10.1177/10711007231153354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foot & Ankle International, 2023. Verfasst von Alexis Hernandez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Femoral Fractures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Prophylactic vancomycin treatment decreases the prevalence of surgical site and deep infections by >70% in diabetic patients undergoing reconstructive foot and ankle surgery. Thus, determining whether clinically relevant local vancomycin doses affect diabetic fracture healing is of medical interest. We hypothesized that application of vancomycin powder to the fracture site during surgery would not affect healing outcomes, but continuous exposure of vancomycin would inhibit differentiation of osteoblast precursor cells and their osteogenic activity in vitro.
Methods
The vancomycin dose used to treat the diabetic rats was a modest increase to routine surgical site vancomycin application of 1 to 2 g for a 70-kg adult (21 mg/kg). After femur fracture in BB-Wistar type 1 diabetic rats, powdered vancomycin (25 mg/kg) was administered to the fracture site. Bone marrow and periosteal cells isolated from diabetic bones were cultured and treated with increasing levels of vancomycin (0, 5, 50, 500, or 5000 µg/mL).
Results
Radiographic scoring, micro–computed tomography (µCT) analysis, and torsion mechanical testing failed to identify any statistical difference between the vancomycin-treated and the untreated fractured femurs 6 weeks postfracture. Low to moderate levels of vancomycin treatment (5 and 50 µg/mL) did not impair cell viability, osteoblast differentiation, or calcium deposition in either the periosteum or bone marrow–derived cell cultures. In contrast, high doses of vancomycin (5000 µg/mL) did impair viability, differentiation, and calcium deposition. Clinical Relevance: In this diabetic rodent fracture model, vancomycin powder application at clinically relevant doses did not affect fracture healing or osteogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA.
- Department of Orthopaedics, Rutgers New Jersey Medical School, Newark, NJ, USA.
ORCID-Profile: Jessica Cottrell
Zitieren
APA
Hernandez, A., Rahman, O., Kadkoy, Y., Lauritsen, K. L., Sanchez, A., Innella, K., Lin, A., Lopez, J., O'Connor, J. P., Benevenia, J., Paglia, D. N., Lin, S. S., & Cottrell, J. (2023). Effect of Vancomycin Applied to the Surgical Site on Fracture Healing in a Diabetic Rat Model. Foot & Ankle International. https://doi.org/10.1177/10711007231153354
Vancouver
Hernandez A, Rahman O, Kadkoy Y, Lauritsen KL, Sanchez A, Innella K, et al. Effect of Vancomycin Applied to the Surgical Site on Fracture Healing in a Diabetic Rat Model. Foot & Ankle International. 2023. doi:10.1177/10711007231153354
BibTeX
@article{Hernandez2023,
author = {Hernandez, Alexis and Rahman, Ohidur and Kadkoy, Yazan and Lauritsen, Katherine L and Sanchez, Alexandra and Innella, Kevin and Lin, Anthony and Lopez, Jonathan and O'Connor, J Patrick and Benevenia, Joseph and Paglia, David N and Lin, Sheldon S and Cottrell, Jessica},
title = {Effect of Vancomycin Applied to the Surgical Site on Fracture Healing in a Diabetic Rat Model},
journal = {Foot & Ankle International},
year = {2023},
doi = {10.1177/10711007231153354}
}
EUVIMED